CB1 agonist protective_against eating disorders

Subject: CB1 agonist
Relation: protective_against
Object: eating disorders
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021) PMID:32064741 primary

initial evidence for the therapeutic effectiveness of cannabinoid agonists in treating eating disorders

confidence: 0.85